目次
Table of Content
1. mRNA Vaccines As Next Generation Cancer Immunotherapy
1.1 mRNA Vaccines Overview
1.2 mRNA Vaccines v/s Other Cancer Therapeutic Approaches
1.3 mRNA Vaccines v/s Other Vaccines
2. Global mRNA Cancer Vaccines Market Overview
2.1 Current Market Trends
2.2 Future Market Commercialization and Clinical Opportunities
3. Global mRNA Cancer Vaccine Clinical Trials Insight By Company, Country, Indication and Phase
3.1 Research
3.2 Preclinical
3.3 Phase I
3.4 Phase I/II
3.5 Phase II
3.6 Phase II/III
3.7 Phase III
4. Global Cancer mRNA Vaccines Clinical Pipeline Overview
4.1 By Company
4.2 By Country
4.3 By Indication
4.4 By Patient Segment
4.5 By Phase
4.6 By Priority Status
5. Global mRNA Cancer Vaccines Clinical Landscape By Indication
5.1 Breast Cancer
5.2 Brain Cancer
5.3 Melanoma
5.4 Head and Neck Cancers
5.5 Lung Cancer
5.6 Cervical Cancer
5.7 Gastrointestinal Cancers
6. Global mRNA Cancer Vaccines Market Trends By Country
6.1 US
6.2 China
6.3 Australia
6.4 Europe
6.5 Canada
6.6 UK
7. Global mRNA Cancer Vaccines Market Collaborations, Deals and Investments
8. Proprietary Technologies and Methodologies For mRNA Cancer Vaccine Development
9. Competitive Landscape
9.1 BioNTech
9.2 Combined Therapeutics
9.3 CureVac
9.4 EpiVax
9.5 HDT Bio
9.6 Immorna
9.7 Immune Design
9.8 MDimune
9.9 Moderna Therapeutics
9.10 NeoCura
9.11 pHion Therapeutics
9.12 Providence Therapeutics
9.13 RinuaGene
9.14 RNAimmune
9.15 TransCode Therapeutics
List of Figures
Figure 4-1: Global - mRNA Cancer Vaccines Clinical Pipeline by Company (Numbers), 2025
Figure 4-2: Global - Number Of mRNA Cancer Vaccines Trials by Country (Numbers), 2025
Figure 4-3: Global - mRNA Cancer Vaccines Clinical Trials by Indication (Numbers), 2025
Figure 4-4: Global - mRNA Cancer Vaccines Clinical Pipeline by Patient Segment (Numbers), 2025
Figure 4-5: Global - mRNA Cancer Vaccines Clinical Pipeline by Phase (Numbers), 2025
Figure 4-6: Global - mRNA Cancer Vaccines Clinical Pipeline by Priority Status (Numbers), 2025
Figure 5-1: KEYNOTE-603 Phase I (NCT03313778) Study - Initiation and Completion Year
Figure 5-2: Autogene Cevumeran Phase I (NCT03289962) Study - Initiation and Completion Year
Figure 5-3: CVGBM Phase I (NCT05938387) Study - Initiation and Completion Year
Figure 5-4: Autogene Cevumeran Phase I (NCT03289962) Study - Initiation and Completion Year
Figure 5-5: BNT111 Phase I (NCT04526899) Study - Initiation and Completion Year
Figure 5-6: mRNA-4157 Phase II (NCT03897881) Study - Initiation and Completion Year
Figure 5-7: mRNA-4157 Phase III (NCT05933577) Study - Initiation and Completion Year
Figure 5-8: BNT113 Phase II (NCT04534205) Study - Initiation and Completion Year
Figure 5-9: mRNA-4157 Phase I (NCT03313778) Study - Initiation and Completion Year
Figure 5-10: V940 Phase III (NCT06077760) Study - Initiation and Completion Year
Figure 5-11: LuCa-MERIT-1 Phase I (NCT05142189) Study - Initiation and Completion Year
Figure 5-12: EMPOWERVAX Lung 1 Phase I (NCT05557591) Study - Initiation and Completion Year
Figure 5-13: Autogene Cevumeran Phase I (NCT04161755) Study - Initiation and Completion Year
Figure 5-14: Autogene cevumeran Phase II (NCT05968326) Study - Initiation and Completion Year
Figure 5-15: BNT122 Phase II (NCT04486378) Study - Initiation and Completion Year
Figure 8-1: BioNTech - uRNA products
Figure 8-2: BioNTech - iNeST technology
Figure 8-3: CureVac - CureVac Method for Generation of mRNA Therapeutics
Figure 8-4: Moderna - mRNA Technology
Figure 8-5: NeoCura - NeoCura Ag Platform
Figure 8-6: Providence Therapeutic - mRNA Medicines Platform Benefits
List of Tables
Table 1-1: mRNA Vaccines v/s Other Cancer Therapeutic Approaches
Table 1-2: mRNA-Based Cancer Vaccines vs. Other Cancer Vaccines
Table 2-1: Regulatory Designations Granted to Investigational mRNA Cancer Vaccines
Table 5-1: Breast Cancer - Some mRNA Vaccines in Clinical Trials
Table 5-2: Brain Cancer - Some mRNA Vaccines in Clinical Trials
Table 5-3: Melanoma - Some mRNA Vaccines in Clinical Trials
Table 5-4: Head and Neck Cancer - mRNA Vaccines in Clinical Trials
Table 5-5: Lung Cancer - Some mRNA Vaccines in Clinical Trials
Table 5-6: Cervical Cancer - Some mRNA Vaccines in Clinical Trials
Table 5-7: Gastrointestinal Cancers - Some mRNA Vaccines in Clinical Trials
